Figure 3: Graded cumulative lifetime exposure of pioglitazone and gender-wise distribution of patients in each group
| Close | |
|
|
|
|
Figure 3: Graded cumulative lifetime exposure of pioglitazone and gender-wise distribution of patients in each group
|
|